266 related articles for article (PubMed ID: 10878289)
1. Inhibition of p38 MAP kinase as a therapeutic strategy.
Lee JC; Kumar S; Griswold DE; Underwood DC; Votta BJ; Adams JL
Immunopharmacology; 2000 May; 47(2-3):185-201. PubMed ID: 10878289
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
Lee JC; Kassis S; Kumar S; Badger A; Adams JL
Pharmacol Ther; 1999; 82(2-3):389-97. PubMed ID: 10454214
[TBL] [Abstract][Full Text] [Related]
3. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.
Kumar S; Boehm J; Lee JC
Nat Rev Drug Discov; 2003 Sep; 2(9):717-26. PubMed ID: 12951578
[TBL] [Abstract][Full Text] [Related]
4. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
6. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.
Kumar S; Jiang MS; Adams JL; Lee JC
Biochem Biophys Res Commun; 1999 Oct; 263(3):825-31. PubMed ID: 10512765
[TBL] [Abstract][Full Text] [Related]
7. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle.
Hallsworth MP; Moir LM; Lai D; Hirst SJ
Am J Respir Crit Care Med; 2001 Aug; 164(4):688-97. PubMed ID: 11520738
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells.
Kujime K; Hashimoto S; Gon Y; Shimizu K; Horie T
J Immunol; 2000 Mar; 164(6):3222-8. PubMed ID: 10706714
[TBL] [Abstract][Full Text] [Related]
10. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
Eyers PA; Craxton M; Morrice N; Cohen P; Goedert M
Chem Biol; 1998 Jun; 5(6):321-8. PubMed ID: 9653550
[TBL] [Abstract][Full Text] [Related]
11. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
12. Pyridinylimidazole based p38 MAP kinase inhibitors.
Jackson PF; Bullington JL
Curr Top Med Chem; 2002 Sep; 2(9):1011-20. PubMed ID: 12171568
[TBL] [Abstract][Full Text] [Related]
13. p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells.
Kintscher U; Bruemmer D; Blaschke F; Unger T; Law RE
Biochem Biophys Res Commun; 2003 Jun; 305(3):552-6. PubMed ID: 12763029
[TBL] [Abstract][Full Text] [Related]
14. Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells.
Igarashi M; Yamaguchi H; Hirata A; Daimon M; Tominaga M; Kato T
Eur J Clin Invest; 2000 Aug; 30(8):668-77. PubMed ID: 10964158
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitor of p38 mitogen-activated protein kinase inhibits lipopolysaccharide-induced interleukin-8 expression in human pulmonary vascular endothelial cells.
Hashimoto S; Gon Y; Matsumoto K; Maruoka S; Takeshita I; Hayashi S; Asai Y; Jibiki I; Machino T; Horie T
J Pharmacol Exp Ther; 2000 May; 293(2):370-5. PubMed ID: 10773004
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase pathways activated by stress: the p38 MAPK pathway.
Obata T; Brown GE; Yaffe MB
Crit Care Med; 2000 Apr; 28(4 Suppl):N67-77. PubMed ID: 10807318
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization.
Gibbs BF; Plath KE; Wolff HH; Grabbe J
J Leukoc Biol; 2002 Aug; 72(2):391-400. PubMed ID: 12149431
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells.
Wang X; Rao J; Studzinski GP
Exp Cell Res; 2000 Aug; 258(2):425-37. PubMed ID: 10896794
[TBL] [Abstract][Full Text] [Related]
19. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha.
Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL
Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794
[TBL] [Abstract][Full Text] [Related]
20. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity.
Reiling N; Blumenthal A; Flad HD; Ernst M; Ehlers S
J Immunol; 2001 Sep; 167(6):3339-45. PubMed ID: 11544323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
